Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tyrosine-modifying glycosylation by Yersinia effectors.

The Journal of biological chemistry·2024
Same author

An Updated View on the Cellular Uptake and Mode-of-Action of Clostridioides difficile Toxins.

Advances in experimental medicine and biology·2024
Same author

Clostridioides difficile infection drives neuronal inflammation.

Nature·2023
Same author

Antibodies Directed Against GalNAc- and GlcNAc-O-Tyrosine Posttranslational Modifications - a New Tool for Glycoproteomic Detection.

Chemistry (Weinheim an der Bergstrasse, Germany)·2023
Same author

Inhibition of Arp2/3 Complex after ADP-Ribosylation of Arp2 by Binary <i>Clostridioides</i> Toxins.

Cells·2022
Same author

From signal transduction to protein toxins-a narrative review about milestones on the research route of C. difficile toxins.

Naunyn-Schmiedeberg's archives of pharmacology·2022

Related Experiment Video

Updated: Jul 5, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

Processing of Clostridium difficile toxins.

Torsten Giesemann1, Martina Egerer1, Thomas Jank1

  • 1Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Universität Freiburg, Albertstrasse 25, D-79104 Freiburg, Germany.

Journal of Medical Microbiology
|May 16, 2008
PubMed
Summary

Clostridium difficile toxins A and B (TcdA and TcdB) cause disease by entering cells. This study reviews how their catalytic domains are processed for cell entry and function.

More Related Videos

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

Related Experiment Videos

Last Updated: Jul 5, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

Area of Science:

  • Microbiology
  • Molecular Biology
  • Cellular Biology

Background:

  • Clostridium difficile pathogenicity is mediated by glucosylating toxins TcdA and TcdB.
  • These toxins possess modular structures with distinct catalytic and binding/translocation domains.
  • Toxin uptake involves proteolytic processing, delivering the catalytic domain to the host cell cytosol.

Purpose of the Study:

  • To provide an overview of recent findings on the intramolecular processing of Clostridium difficile toxins.
  • To highlight the role of intrinsic protease activity in toxin activation.

Main Methods:

  • Review of existing literature on Clostridium difficile toxin structure and function.
  • Analysis of studies investigating toxin processing and translocation mechanisms.

Main Results:

  • The catalytic domain of TcdA and TcdB is released via intramolecular proteolytic cleavage.
  • This processing is essential for the toxins to reach the cytosol and exert their enzymatic activity.
  • Glucosyltransferases inactivate host cell small GTPases through mono-O-glucosylation.

Conclusions:

  • Understanding the intramolecular processing of Clostridium difficile toxins is crucial for comprehending their pathogenicity.
  • The intrinsic protease activity plays a key role in delivering the active toxin domain into host cells.
  • Targeting this processing mechanism could offer novel therapeutic strategies against C. difficile infections.